Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dyspepsia and GERD: breaking the rules.

Nimish Vakil

    The American Journal of Gastroenterology
    |June 30, 2005
    PubMed
    Summary
    This summary is machine-generated.

    Empirical proton pump inhibitor (PPI) therapy offers a cost-effective approach for managing uninvestigated dyspepsia. This treatment is particularly suitable for young patients without Helicobacter pylori infection, avoiding the need for endoscopy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Does Treatment of <i>Helicobacter pylori</i> Infection Pose a Risk to Patients With GERD?

    Gastroenterology & hepatology·2026
    Same author

    Gastric cancer secondary prevention in dyspeptic patients.

    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026
    Same author

    Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA-Labeled Dosing Frequency of RHB-105 Low-Dose Rifabutin Triple Therapy for Helicobacter pylori Eradication.

    Journal of clinical pharmacology·2025
    Same author

    Peptic Ulcer Disease: A Review.

    JAMA·2024
    Same author

    Endoscopic Diagnosis, Grading, and Treatment of Bleeding Peptic Ulcer Disease.

    Gastrointestinal endoscopy clinics of North America·2024
    Same author

    Developments in Gastroesophageal Reflux Disease over the Last 40 Years.

    Digestive diseases (Basel, Switzerland)·2023

    Area of Science:

    • Gastroenterology
    • Clinical Medicine
    • Health Economics

    Background:

    • Dyspepsia is a prevalent gastrointestinal disorder encountered frequently in clinical settings.
    • Economic evaluations indicate that empirical proton pump inhibitor (PPI) therapy may be a cost-effective strategy for managing uninvestigated dyspepsia.

    Discussion:

    • Empirical PPI therapy presents a viable and attractive alternative to invasive endoscopic procedures for diagnosing dyspepsia.
    • This approach is especially relevant for younger patients diagnosed with dyspepsia.

    Key Insights:

    • Proton pump inhibitors (PPIs) can be used empirically for dyspepsia management.
    • Cost-effectiveness favors empirical PPIs over endoscopy in specific patient groups.
    • Helicobacter pylori status is a critical factor in treatment decisions.

    Related Experiment Videos

    Outlook:

    • Further research could explore long-term outcomes and patient-reported benefits of empirical PPI therapy.
    • Comparative studies evaluating PPIs against other dyspepsia treatments may refine clinical guidelines.
    • Integration of economic modeling into clinical practice guidelines for dyspepsia management is recommended.